In Episode 64, we continue to unpack the regulatory evolution of cannabis and cannabidiol (CBD) in Canada (continuation of Episode 44) and what’s next for the industry. From the Cannabis Act to proposed pathways that could finally allow CBD Natural Health Products (NHPs) to be sold without prescriptions, this episode dives deep into how Health Canada’s changing stance could reshape accessibility, innovation, and economic opportunity.

For most Americans, a government shutdown means furloughs, temporary disruptions that end when funding returns. But October 2025 marks a turning point. The Trump administration’s move to issue Reductions in Force (RIFs) across key agencies like HHS, FDA, and the CDC has transformed a short-term budget standoff into a permanent restructuring of the federal workforce.

In this episode, we break down:

• The difference between a furlough and a RIF, and why it matters now more than ever.

• The scale of workforce reductions and their ripple effects on public health and food safety.

• The political and economic motivations behind using the shutdown as a tool to shrink government size.

• Historical parallels to past administrations and what they reveal about the long-term agenda.

Tune in to explore how this unprecedented move could reshape America’s public health infrastructure, and redefine the meaning of “non-essential.”

After nearly three years of uncertainty, the FDA has officially reversed its stance on Nicotinamide Mononucleotide (NMN), the popular anti-aging compound once banned from supplement shelves.

In this episode, we unpack the twists and turns that led to the agency’s dramatic U-turn, the key legal reinterpretation that changed everything, and how relentless industry advocacy forced the FDA’s hand.

From Citizen Petitions to regulatory chaos, discover what really happened behind the scenes, and why this win for NMN could foreshadow the next big battle in dietary supplement regulation.

Tune in to understand the future of NMN, the gaps still left unaddressed, and what this means for innovation in the supplement industry.